The ITHS Technology Development Center is staffed with clinical, regulatory, and commercialization experts to assist academic and industry innovators through translation, startup formation, clinical study, regulatory clearance, fundraising, and market entry.
We welcome all for an initial consultation, in which we identify resources and define a scope of work optimized for the advancement of your small molecule, biologic, medical device, or digital health application. No matter where you are on your journey to commercialization, we can help you find the services, funding, and programs you need to move you forward. Explore what we have to offer below!
Services and support to help you get started on your journey: IP cultivation, customer discovery, fellowships, degrees, and academic programs for health science innovators.
Proof of Concept
Support to strengthen the spark of your idea: customer discovery, regulatory strategy, FDA law, and the funding to keep you forging ahead.
Strategic advice and funding to aid you as you move toward commercialization: pre-clinical study, market research, business plan development, community engagement, mentorship for all sorts of entrepreneurs.
Final Steps to Startup
Support for human study, FDA clearance, and company formation: study design and coordination; assistance with equity, diversity and inclusion; legal counsel; grant writing; pitch practice; and investor connections.
We offer free initial consultations with the following services provided for a fee billable to your department or organization.
DDAC reviews proposed innovations and provides free consultations to discuss specific pre-clinical development plans, focusing on tasks needed to efficiently move the drug to the clinic according to FDA guidelines.
As director of the Technology Development Center, Teddy Johnson’s goal is to help entrepreneurs bring new health tech to market. His years of experience have given him the knowledge and connections to guide you on the path to success. Feel free to reach out to Teddy any time you have a question about your next steps.
Dr. Terri Butler works with faculty and students at the University of Washington and collaborating Pacific Northwest research institutions advising on commercialization pathways for biomedical technologies. She is the primary contact for the ITHS Drug and Device Advisory Committee and manages the WE-REACH Biomedical Innovation Bootcamp.
Dr. Lynn Rose serves as a regulatory consultant and advisor for the ITHS Technology Development Center. Her goal is to help investigators understand the regulatory basis for development of their medical product idea and to facilitate entry into the clinical phase as quickly as possible. As a regulatory consultant for the ITHS, she primarily assists investigators with the development of a regulatory strategy, clinical protocols and the creation and submission of Investigational New Drug and Investigational Device Exemption applications to the FDA.
Target Product Profile Video
GANTT Project Plan Video